ORGC — Organoclick AB Income Statement
0.000.00%
Last trade - 00:00
- SEK308.54m
- SEK355.07m
- SEK145.87m
- 28
- 16
- 49
- 19
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 85.5 | 96.5 | 110 | 115 | 146 |
Cost of Revenue | |||||
Gross Profit | 17.3 | 19.4 | 16 | 11.1 | 34.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 101 | 114 | 139 | 154 | 155 |
Operating Profit | -15.1 | -17.1 | -28.6 | -38.5 | -9.23 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -18.8 | -19.5 | -31.2 | -41.7 | -14.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18.4 | -19.5 | -31 | -41.6 | -14.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -20.4 | -23.6 | -32.7 | -44.4 | -15.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -20.4 | -23.6 | -32.7 | -44.4 | -15.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.255 | -0.265 | -0.342 | -0.41 | -0.161 |
Dividends per Share |